BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 van der Gaag NA, Kloek JJ, de Bakker JK, Musters B, Geskus RB, Busch OR, Bosma A, Gouma DJ, van Gulik TM. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol. 2012;23:2642-2649. [PMID: 22532585 DOI: 10.1093/annonc/mds077] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
2 Kim KB, Choi DW, Heo JS, Han IW, Shin SH, You Y, Park DJ. The impact of portal vein resection on outcome of hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:221-9. [PMID: 34053925 DOI: 10.14701/ahbps.2021.25.2.221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36:2179-2186. [PMID: 22569746 DOI: 10.1007/s00268-012-1638-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
4 Kloek JJ, van der Gaag NA, Erdogan D, Rauws EA, Busch OR, Gouma DJ, ten Kate FJ, van Gulik TM. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Hum Pathol. 2011;42:824-832. [PMID: 21292296 DOI: 10.1016/j.humpath.2010.09.017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
5 Gomez D, Patel P, Lacasia-purroy C, Byrne C, Sturgess R, Palmer D, Fenwick S, Poston G, Malik H. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2014;40:77-84. [DOI: 10.1016/j.ejso.2013.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
6 Kim YS, Hwang IG, Park S, Go S, Kang J, Park I, Oh SY, Ji JH, Song H, Park SH, Kim ST, Park JO. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Cancer Chemother Pharmacol 2016;77:979-85. [DOI: 10.1007/s00280-016-3014-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
7 Tella SH, Kommalapati A, Yadav S, Bergquist JR, Goyal G, Durgin L, Borad M, Cleary SP, Truty MJ, Mahipal A. Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival. Eur J Surg Oncol 2020;46:789-95. [PMID: 31954549 DOI: 10.1016/j.ejso.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Huang XQ, Shu J, Luo L, Jin ML, Lu XF, Yang SG. Differentiation grade for extrahepatic bile duct adenocarcinoma: Assessed by diffusion-weighted imaging at 3.0-T MR. Eur J Radiol 2016;85:1980-6. [PMID: 27776649 DOI: 10.1016/j.ejrad.2016.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
9 Ruys AT, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma. HPB Surg 2013;2013:657309. [PMID: 23861556 DOI: 10.1155/2013/657309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
10 Catenacci DV, Chapman CG, Xu P, Koons A, Konda VJ, Siddiqui UD, Waxman I. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound. Gastroenterology. 2015;149:1794-1803.e4. [PMID: 26341722 DOI: 10.1053/j.gastro.2015.08.050] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 12.7] [Reference Citation Analysis]
11 van Gulik TM, Kloek JJ, Ruys AT, Busch OR, van Tienhoven GJ, Lameris JS, Rauws EA, Gouma DJ. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol. 2011;37:65-71. [PMID: 21115233 DOI: 10.1016/j.ejso.2010.11.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
12 Schlitter AM, Esposito I. Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel). 2010;2:2001-2010. [PMID: 24281214 DOI: 10.3390/cancers2042001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
13 van der Gaag N, Kloek J, de Bakker J, Musters B, Geskus R, Busch O, Bosma A, Gouma D, van Gulik T. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Annals of Oncology 2012;23:2642-9. [DOI: 10.1093/annonc/mds077] [Reference Citation Analysis]
14 Abdelwahab M, El Nakeeb A, Salah T, Hamed H, Ali M, El Sorogy M, Shehta A, Ezatt H, Sultan AM, Zalata K. Hilar cholangiocarcinoma in cirrhotic liver: a case-control study. Int J Surg. 2014;12:762-767. [PMID: 24909136 DOI: 10.1016/j.ijsu.2014.05.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Hoffmann K, Luible S, Goeppert B, Weiss K, Hinz U, Büchler MW, Schemmer P. Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma. Surgery 2015;158:1252-60. [DOI: 10.1016/j.surg.2015.04.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
16 Koh HK, Park HJ, Kim K, Chie EK, Min HS, Ha SW. Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery. Radiat Oncol J 2012;30:197-204. [PMID: 23346539 DOI: 10.3857/roj.2012.30.4.197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol 2013; 5(7): 147-158 [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
18 Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2014;9:491-502. [DOI: 10.1586/era.09.5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
19 Schiffman SC, Reuter NP, McMasters KM, Scoggins CR, Martin RC. Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol. 2012;105:91-96. [PMID: 21815152 DOI: 10.1002/jso.22054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
20 Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87 [PMID: 23671735 DOI: 10.4251/wjgo.v5.i4.81] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
21 Aitken K, Hawkins M. The Role of Radiotherapy and Chemoradiation in the Management of Primary Liver Tumours. Clinical Oncology 2014;26:569-80. [DOI: 10.1016/j.clon.2014.05.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]